Long-term efficacy and safety of momelotinib, a JAK1 and JAK2 inhibitor, for the treatment of myelofibrosis

Animesh D Pardanani, J. Gotlib, A. W. Roberts, M. Wadleigh, S. Sirhan, J. Kawashima, J. A. Maltzman, L. Shao, V. Gupta, Ayalew Tefferi

Research output: Contribution to journalLetterpeer-review

9 Scopus citations
Original languageEnglish (US)
Pages (from-to)1034-1037
Number of pages4
JournalLeukemia
Volume32
Issue number4
DOIs
StatePublished - Apr 1 2018

ASJC Scopus subject areas

  • Hematology
  • Cancer Research
  • Anesthesiology and Pain Medicine

Cite this